S&P 500   3,888.69 (+2.03%)
DOW   31,579.46 (+2.09%)
QQQ   320.31 (+1.96%)
AAPL   124.89 (+2.99%)
MSFT   236.44 (+1.75%)
FB   259.80 (+0.85%)
GOOGL   2,047.00 (+1.24%)
TSLA   707.15 (+4.69%)
AMZN   3,105.70 (+0.41%)
NVDA   546.09 (-0.45%)
BABA   240.65 (+1.22%)
CGC   34.60 (+5.65%)
GE   13.19 (+5.18%)
MU   93.91 (+2.60%)
NIO   49.38 (+7.86%)
AMD   85.01 (+0.59%)
T   28.38 (+1.76%)
F   11.94 (+2.05%)
ACB   11.19 (+6.37%)
DIS   195.25 (+3.29%)
BA   226.51 (+6.84%)
NFLX   548.15 (+1.73%)
BAC   35.71 (+2.88%)
S&P 500   3,888.69 (+2.03%)
DOW   31,579.46 (+2.09%)
QQQ   320.31 (+1.96%)
AAPL   124.89 (+2.99%)
MSFT   236.44 (+1.75%)
FB   259.80 (+0.85%)
GOOGL   2,047.00 (+1.24%)
TSLA   707.15 (+4.69%)
AMZN   3,105.70 (+0.41%)
NVDA   546.09 (-0.45%)
BABA   240.65 (+1.22%)
CGC   34.60 (+5.65%)
GE   13.19 (+5.18%)
MU   93.91 (+2.60%)
NIO   49.38 (+7.86%)
AMD   85.01 (+0.59%)
T   28.38 (+1.76%)
F   11.94 (+2.05%)
ACB   11.19 (+6.37%)
DIS   195.25 (+3.29%)
BA   226.51 (+6.84%)
NFLX   548.15 (+1.73%)
BAC   35.71 (+2.88%)
S&P 500   3,888.69 (+2.03%)
DOW   31,579.46 (+2.09%)
QQQ   320.31 (+1.96%)
AAPL   124.89 (+2.99%)
MSFT   236.44 (+1.75%)
FB   259.80 (+0.85%)
GOOGL   2,047.00 (+1.24%)
TSLA   707.15 (+4.69%)
AMZN   3,105.70 (+0.41%)
NVDA   546.09 (-0.45%)
BABA   240.65 (+1.22%)
CGC   34.60 (+5.65%)
GE   13.19 (+5.18%)
MU   93.91 (+2.60%)
NIO   49.38 (+7.86%)
AMD   85.01 (+0.59%)
T   28.38 (+1.76%)
F   11.94 (+2.05%)
ACB   11.19 (+6.37%)
DIS   195.25 (+3.29%)
BA   226.51 (+6.84%)
NFLX   548.15 (+1.73%)
BAC   35.71 (+2.88%)
S&P 500   3,888.69 (+2.03%)
DOW   31,579.46 (+2.09%)
QQQ   320.31 (+1.96%)
AAPL   124.89 (+2.99%)
MSFT   236.44 (+1.75%)
FB   259.80 (+0.85%)
GOOGL   2,047.00 (+1.24%)
TSLA   707.15 (+4.69%)
AMZN   3,105.70 (+0.41%)
NVDA   546.09 (-0.45%)
BABA   240.65 (+1.22%)
CGC   34.60 (+5.65%)
GE   13.19 (+5.18%)
MU   93.91 (+2.60%)
NIO   49.38 (+7.86%)
AMD   85.01 (+0.59%)
T   28.38 (+1.76%)
F   11.94 (+2.05%)
ACB   11.19 (+6.37%)
DIS   195.25 (+3.29%)
BA   226.51 (+6.84%)
NFLX   548.15 (+1.73%)
BAC   35.71 (+2.88%)
Log in
CVE:LBL

Lattice Biologics News Headlines

C$0.06
0.00 (0.00 %)
(As of 03/1/2021 09:30 AM ET)
Add
Compare
Today's Range
C$0.06
Now: C$0.06
C$0.06
50-Day Range
C$0.00
MA: C$0.07
C$0.13
52-Week Range
C$0.02
Now: C$0.06
C$0.21
Volume1,000 shs
Average Volume860,949 shs
Market CapitalizationC$7.69 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Lattice Biologics (CVE LBL) News Headlines Today

Source:
SourceHeadline
Lattice Biologics (CVE:LBL) Share Price Passes Below Fifty Day Moving Average of $0.07Lattice Biologics (CVE:LBL) Share Price Passes Below Fifty Day Moving Average of $0.07
americanbankingnews.com - February 17 at 4:18 AM
Depth Filtration Market Research By Key Players, Type And Application, Future Growth To 2026Depth Filtration Market Research By Key Players, Type And Application, Future Growth To 2026
marketwatch.com - December 14 at 8:50 AM
Lattice Biologics Ltd. Reports Q3 2020 ResultsLattice Biologics Ltd. Reports Q3 2020 Results
businesswire.com - August 31 at 8:11 PM
Lattice Biologics Ltd. (LBLTF)Lattice Biologics Ltd. (LBLTF)
finance.yahoo.com - August 14 at 12:26 PM
What Did Lattice Biologics (CVE:LBL) CEO Take Home Last Year?What Did Lattice Biologics' (CVE:LBL) CEO Take Home Last Year?
finance.yahoo.com - July 23 at 8:34 AM
190,524190,524
www.businesswire.com - June 2 at 1:28 PM
Lattice Biologics UpdateLattice Biologics Update
www.businesswire.com - May 11 at 4:04 PM
Health-Related Concerns Have Exciting, Stock-Moving NewsHealth-Related Concerns Have Exciting, Stock-Moving News
www.baystreet.ca - April 15 at 5:28 PM
Lattice Biologics Ltd. Announces Option RepricingLattice Biologics Ltd. Announces Option Repricing
finance.yahoo.com - April 15 at 5:28 PM
Lattice Biologics Announces Planned Debt-to-Equity ConversionLattice Biologics Announces Planned Debt-to-Equity Conversion
finance.yahoo.com - March 11 at 10:48 PM
LATTICE BIOLOGICS LTD. Transferred To TSX Venture Exchange Tier 2LATTICE BIOLOGICS LTD. Transferred To TSX Venture Exchange Tier 2
finance.yahoo.com - March 3 at 8:04 PM
Lattice Biologics Ltd. Reports Q1 2020 ResultsLattice Biologics Ltd. Reports Q1 2020 Results
www.businesswire.com - February 28 at 3:20 PM
Did Changing Sentiment Drive Lattice Biologicss (CVE:LBL) Share Price Down A Painful 90%?Did Changing Sentiment Drive Lattice Biologics's (CVE:LBL) Share Price Down A Painful 90%?
finance.yahoo.com - November 19 at 10:30 PM
What Kind Of Share Price Volatility Should You Expect For Lattice Biologics Ltd. (CVE:LBL)?What Kind Of Share Price Volatility Should You Expect For Lattice Biologics Ltd. (CVE:LBL)?
finance.yahoo.com - August 21 at 3:56 PM
Lattice Biologics Ltd. Reports Second Quarter 2019 ResultsLattice Biologics Ltd. Reports Second Quarter 2019 Results
www.businesswire.com - May 31 at 2:55 AM
Lattice Biologics LtdLattice Biologics Ltd
www.bloomberg.com - March 19 at 5:55 AM
Lattice Biologics Ltd. Reports First Quarter 2019 ResultsLattice Biologics Ltd. Reports First Quarter 2019 Results
www.marketwatch.com - March 1 at 3:27 PM
This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.